Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: Analysis of commercial insurance claims data, United States.
作者信息
Gold Jeremy A W, Wu Karen, Jackson Brendan R, Benedict Kaitlin
机构信息
Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
出版信息
J Am Acad Dermatol. 2023 Mar;88(3):683-686. doi: 10.1016/j.jaad.2022.06.1201. Epub 2022 Jul 7.
Abstract
摘要
相似文献
1
Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: Analysis of commercial insurance claims data, United States.改善甲癣诊断和治疗指南依从性的机会：美国商业保险理赔数据分析
J Am Acad Dermatol. 2023 Mar;88(3):683-686. doi: 10.1016/j.jaad.2022.06.1201. Epub 2022 Jul 7.
2
Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study.新抗真菌药物对日本甲真菌病处方和费用的影响：一项全国性索赔数据库研究。
J Dermatol. 2024 Sep;51(9):1172-1179. doi: 10.1111/1346-8138.17393. Epub 2024 Aug 8.
3
Readers' perspectives. Claims management software vendor and claims clearinghouse.
Health Data Manag. 2003 Dec;11(12):64.
4
Getting claims paid in a HIPAA world.
Health Data Manag. 2003 Oct;11(10):68-70.
5
When claims are audited, following compliance laws matters.当理赔进行审核时，遵守合规法律很重要。
Manag Care. 2001 Jan;10(1):68-9.
6
The silver lining. Why HIPAA can be good for your claims process.一线希望。为何《健康保险流通与责任法案》对你的理赔流程有益。
MGMA Connex. 2003 Mar;3(3):26-7.
7
GAO evaluates implementation of False Claims Act guidance.美国政府问责局评估《虚假索赔法》指南的实施情况。
J AHIMA. 1999 Nov-Dec;70(10):19-20.
8
Guideline adherence in speech and language therapy in stroke aftercare. A health insurance claims data analysis.脑卒中康复治疗中言语和语言治疗的指南遵循情况。一项医疗保险索赔数据分析。
PLoS One. 2022 Feb 3;17(2):e0263397. doi: 10.1371/journal.pone.0263397. eCollection 2022.
9
Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.药物治疗依从性的差异与慢性阻塞性肺疾病全球倡议（GOLD）：回顾性 actuarial 理赔数据分析。
Curr Med Res Opin. 2011 Jul;27(7):1425-9. doi: 10.1185/03007995.2011.583230. Epub 2011 May 23.
10
Payers required to adopt standardized electronic claims processing.付款人需要采用标准化的电子索赔处理方式。
Healthc Financ Manage. 1998 Jan;52(1):62-4.
引用本文的文献
1
Scratching the surface: The rise of antifungal-resistant dermatophytes.触及表面：抗真菌皮肤癣菌的兴起
Clin Microbiol Newsl. 2025 Jun;51:26-30. doi: 10.1016/j.clinmicnews.2025.04.003.
2
Risk of Superficial Fungal Infections in WHIM Syndrome.WHIM 综合征中浅表真菌感染的风险。
Dermatol Ther (Heidelb). 2025 May;15(5):1173-1179. doi: 10.1007/s13555-025-01396-0. Epub 2025 Apr 3.
3
Analysis of Causative Factors and Potential Predictors of Onychomycosis: A Retrospective Single-Center Study in Poland.甲癣的致病因素及潜在预测因素分析：波兰一项回顾性单中心研究
J Fungi (Basel). 2025 Feb 9;11(2):131. doi: 10.3390/jof11020131.
4
Patient Characteristics, Diagnostic Testing Utilization, and Antifungal Prescribing Pattern for Onychomycosis in the USA: A Cohort Study Using DataDerm, 2016-2022.美国甲癣的患者特征、诊断检测利用情况及抗真菌药物处方模式：一项使用DataDerm数据的队列研究，2016 - 2022年
Skin Appendage Disord. 2025 Feb;11(1):36-44. doi: 10.1159/000540704. Epub 2024 Aug 29.
5
Epidemiological trends and healthcare disparities in onychomycosis: An analysis of the All of Us research program.甲癣的流行病学趋势与医疗保健差异：“我们所有人”研究项目分析
PLoS One. 2025 Jan 14;20(1):e0316681. doi: 10.1371/journal.pone.0316681. eCollection 2025.
6
Onychomycosis in the US Pediatric Population-An Emphasis on Fusarium Onychomycosis.美国儿科人群中的甲癣——重点关注镰刀菌性甲癣
Pediatr Dermatol. 2025 Jan-Feb;42(1):47-53. doi: 10.1111/pde.15785. Epub 2024 Oct 18.
7
Epidemiology of Onychomycosis in the United States Characterized Using Molecular Methods, 2015-2024.2015 - 2024年美国采用分子方法表征的甲癣流行病学
J Fungi (Basel). 2024 Sep 5;10(9):633. doi: 10.3390/jof10090633.
8
Concealing Meets Healing in the Treatment of Toenail Onychomycosis: A Review of Concurrent Nail Polish Use with Topical Efinaconazole 10% Solution.在治疗趾甲甲真菌病中隐藏与治愈：关于 10% 艾氟康唑溶液与指甲油同时使用的综述
J Clin Aesthet Dermatol. 2024 Sep;17(9):38-42.
9
Clinical Diagnosis and Laboratory Testing of Abnormal Appearing Toenails: A Retrospective Assessment of Confirmatory Testing for Onychomycosis in the United States, 2022-2023.外观异常趾甲的临床诊断与实验室检测：2022 - 2023年美国甲真菌病确诊检测的回顾性评估
J Fungi (Basel). 2024 Feb 13;10(2):149. doi: 10.3390/jof10020149.
10
------Topical Antifungal Prescribing for Medicare Part D Beneficiaries - United States, 2021.----
2021 年美国医疗保险处方药计划（Medicare Part D）参保者局部用抗真菌药物处方情况。
MMWR Morb Mortal Wkly Rep. 2024 Jan 11;73(1):1-5. doi: 10.15585/mmwr.mm7301a1.
本文引用的文献
1
Treatment-resistant dermatophytosis: A representative case highlighting an emerging public health threat.难治性皮肤癣菌病：一个凸显新出现的公共卫生威胁的典型病例
JAAD Case Rep. 2020 Jun 3;6(11):1153-1155. doi: 10.1016/j.jdcr.2020.05.025. eCollection 2020 Nov.
2
Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.四种口服抗真菌药物（氟康唑、灰黄霉素、伊曲康唑和特比萘芬）在印度当前皮肤癣菌病流行中的疗效有限：一项随机实用试验的结果
Br J Dermatol. 2020 Nov;183(5):840-846. doi: 10.1111/bjd.19146. Epub 2020 Jun 15.
3
Diagnostic testing for onychomycosis: A retrospective study over 17 years.甲癣的诊断检测：一项为期17年的回顾性研究。
J Am Acad Dermatol. 2020 Jul;83(1):239-241. doi: 10.1016/j.jaad.2019.12.019. Epub 2019 Dec 14.
4
Onychomycosis: diagnosis and definition of cure.甲癣：诊断与治愈的定义
J Am Acad Dermatol. 2007 Jun;56(6):939-44. doi: 10.1016/j.jaad.2006.12.019. Epub 2007 Feb 16.
5
Guidelines of care for superficial mycotic infections of the skin: onychomycosis. Guidelines/Outcomes Committee. American Academy of Dermatology.皮肤浅表真菌病治疗指南：甲真菌病。指南/结果委员会。美国皮肤病学会。
J Am Acad Dermatol. 1996 Jan;34(1):116-21. doi: 10.1016/s0190-9622(96)90843-9.
Zotero 插件